Enteris BioPharma and Cara Therapeutics Enter into Licensing Agreement for Peptelligence to Advance Development of Oral KORSUVA Read more
FDA Grants XTANDI (enzalutamide) Application Priority Review for the Treatment of Men with Metastatic Hormone-Sensitive Prostate Cancer Read more
Pfizer Invests Half Billion Dollars to Advance State-of-the-Art Gene Therapy Facility in Sanford, North Carolina Read more
Innovent Enters a Licensing Agreement with Lilly to Develop & Commercialize a Novel Diabetes Medicine in China Read more
Emendo Biotherapeutics Achieves Milestone of Collaboration with Takeda for its OMNI Nuclease Program Read more
Tonix Pharma Expands Preclinical Pipeline with Triple Reuptake Inhibitor, TNX-1600, for the Treatment of PTSD Read more
FDA Accepts New Drug Application for VX-445 (Elexacaftor), Tezacaftor and Ivacaftor Combination Treatment Read more